Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 1
1979 1
1988 1
1989 1
1990 1
1992 1
1993 2
1994 1
1997 1
2000 1
2004 1
2008 2
2009 2
2010 2
2011 1
2013 1
2014 1
2016 1
2017 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
Montalban X, Hauser SL, Kappos L, Arnold DL, Bar-Or A, Comi G, de Seze J, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Rammohan KW, Selmaj K, Traboulsee A, Sauter A, Masterman D, Fontoura P, Belachew S, Garren H, Mairon N, Chin P, Wolinsky JS; ORATORIO Clinical Investigators. Montalban X, et al. N Engl J Med. 2017 Jan 19;376(3):209-220. doi: 10.1056/NEJMoa1606468. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002688 Free article. Clinical Trial.
Worksite stress management interventions.
Ivancevich JM, Matteson MT, Freedman SM, Phillips JS. Ivancevich JM, et al. Among authors: freedman sm. Am Psychol. 1990 Feb;45(2):252-61. doi: 10.1037//0003-066x.45.2.252. Am Psychol. 1990. PMID: 2178505 Review.
Disrupted inhibitory plasticity and homeostasis in Fragile X syndrome.
Cea-Del Rio CA, Nunez-Parra A, Freedman SM, Kushner JK, Alexander AL, Restrepo D, Huntsman MM. Cea-Del Rio CA, et al. Among authors: freedman sm. Neurobiol Dis. 2020 Aug;142:104959. doi: 10.1016/j.nbd.2020.104959. Epub 2020 Jun 6. Neurobiol Dis. 2020. PMID: 32512151 Free PMC article.
Fingolimod therapy and macular hemorrhage.
Bhatti MT, Freedman SM, Mahmoud TH. Bhatti MT, et al. Among authors: freedman sm. J Neuroophthalmol. 2013 Dec;33(4):370-2. doi: 10.1097/WNO.0b013e31829b42e1. J Neuroophthalmol. 2013. PMID: 23845997
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.
Cohen JA, Barkhof F, Comi G, Hartung HP, Khatri BO, Montalban X, Pelletier J, Capra R, Gallo P, Izquierdo G, Tiel-Wilck K, de Vera A, Jin J, Stites T, Wu S, Aradhye S, Kappos L; TRANSFORMS Study Group. Cohen JA, et al. N Engl J Med. 2010 Feb 4;362(5):402-15. doi: 10.1056/NEJMoa0907839. Epub 2010 Jan 20. N Engl J Med. 2010. PMID: 20089954 Free article. Clinical Trial.
GLANCE: results of a phase 2, randomized, double-blind, placebo-controlled study.
Goodman AD, Rossman H, Bar-Or A, Miller A, Miller DH, Schmierer K, Lublin F, Khan O, Bormann NM, Yang M, Panzara MA, Sandrock AW; GLANCE Investigators. Goodman AD, et al. Neurology. 2009 Mar 3;72(9):806-12. doi: 10.1212/01.wnl.0000343880.13764.69. Neurology. 2009. PMID: 19255407 Free PMC article. Clinical Trial.
Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis.
Radue EW, Stuart WH, Calabresi PA, Confavreux C, Galetta SL, Rudick RA, Lublin FD, Weinstock-Guttman B, Wynn DR, Fisher E, Papadopoulou A, Lynn F, Panzara MA, Sandrock AW; SENTINEL Investigators. Radue EW, et al. J Neurol Sci. 2010 May 15;292(1-2):28-35. doi: 10.1016/j.jns.2010.02.012. Epub 2010 Mar 16. J Neurol Sci. 2010. PMID: 20236661 Clinical Trial.
24 results